The comorbidity of epilepsy and depression: diagnosis and treatment. (Q38872053)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

review article

1 reference

title

The comorbidity of epilepsy and depression: diagnosis and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

Kaiyan Tao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

1 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

14 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

1321-1333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

Depression and Anxiety among Patients with Epilepsy and Multiple Sclerosis: UAE Comparative Study.

14 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Prevalence of depressive symptoms and their impact on quality of life in patients with drug-resistant focal epilepsy (IMDYVA study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Suicidal risk, affective dysphoric disorders, and quality-of-life perception in patients with focal refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Mortality in patients with refractory temporal lobe epilepsy at a tertiary center in Cuba

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Suicidality and Its Risk Factors in Korean People with Epilepsy: A MEPSY Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Suicide and epilepsy: do antiepileptic drugs increase the risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Functional connectivity abnormalities vary by amygdala subdivision and are associated with psychiatric symptoms in unilateral temporal epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

The effect of depression on academic achievement in children with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Depression and suicide attempt as risk factors for incident unprovoked seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Activation of brain indoleamine 2,3-dioxygenase contributes to epilepsy-associated depressive-like behavior in rats with chronic temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Changes in depression and anxiety after resective surgery for epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Interictal depression, anxiety, personality traits, and psychological dissociation in patients with temporal lobe epilepsy (TLE) and extra-TLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Clinical risk factors for depressive symptoms in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Determinants of depression among patients with epilepsy in Athens, Greece

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Severity of depressive symptomatology and functional impairment in children and adolescents with temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Suicidal risk and suicide attempts in people treated with antiepileptic drugs for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Self reported adverse effects of mono and polytherapy for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Predictors of pharmacoresistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Psychiatric adverse events during vigabatrin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Vigabatrin and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Vigabatrin and behaviour disorders: a retrospective survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Topiramate prescribing patterns among medicaid patients: diagnosis, comorbidities, and dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Topiramate and psychiatric adverse events in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

The role of hippocampal sclerosis in topiramate-related depression and cognitive deficits in people with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

The role of titration schedule of topiramate for the development of depression in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Adjunctive levetiracetam in children, adolescents, and adults with primary generalized seizures: open-label, noncomparative, multicenter, long-term follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Psychiatric adverse events during levetiracetam therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Probable levetiracetam-associated depression in the elderly: two case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Levetiracetam-induced depression in a 5-year-old child with partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Apparent dose-dependent levetiracetam-induced de novo major depression with suicidal behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Profiling the evolution of depression after epilepsy surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Risk factors for postoperative depression: A retrospective analysis of 248 subjects operated on for drug-resistant epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Mood disturbance before and after seizure surgery: a comparison of temporal and extratemporal resections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Epilepsy surgery and postoperative depression: charting difficult territory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Characterising de novo depression after epilepsy surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Relationship between post-operative depression/anxiety and hippocampal/amygdala volumes in temporal lobectomy for epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Individual, seizure-related, and psychosocial predictors of depressive symptoms among people with epilepsy over six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

The association between depression and epilepsy in a nationally representative sample.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Depression and anxiety in women with epilepsy during pregnancy and after delivery: a prospective population-based cohort study on frequency, risk factors, medication, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Depression among people with epilepsy in Northwest Ethiopia: a cross-sectional institution based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Depression in epilepsy: etiology, phenomenology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Severe depression as the sole symptom of affective focal status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Epilepsy-induced behavioral changes during the ictal phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Anger is a distinctive feature of epilepsy patients with depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Phenomenology of depression in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

The interictal dysphoric disorder of epilepsy: a still open debate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

The interictal dysphoric disorder in patients with epilepsy: A doubtful disorder lacking diagnostic tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Acute Unstable Depressive Syndrome (AUDS) is associated more frequently with epilepsy than major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Interleukin-1β causes fluoxetine resistance in an animal model of epilepsy-associated depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Elevated plasma corticosterone level and depressive behavior in experimental temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Plasticity of Presynaptic and Postsynaptic Serotonin 1A Receptors in an Animal Model of Epilepsy-Associated Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Comorbidity between epilepsy and depression: experimental evidence for the involvement of serotonergic, glucocorticoid, and neuroinflammatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

5-HT1A receptor binding in temporal lobe epilepsy patients with and without major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Dopamine abnormalities in the neocortex of patients with temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Increased ratio of glutamate/glutamine to creatine in the right hippocampus contributes to depressive symptoms in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Inhibition of glutamine synthetase in the central nucleus of the amygdala induces anhedonic behavior and recurrent seizures in a rat model of mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Histamine: a new immunomodulatory player in the neuron-glia crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Abnormalities in Monoamine Levels in the Central Nervous System of the Genetically Epilepsy-Prone Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Cortical thickness abnormalities associated with depressive symptoms in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Major depression in temporal lobe epilepsy with hippocampal sclerosis: clinical and imaging correlates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Severe hippocampal atrophy is not associated with depression in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Resting-state fMRI study of treatment-naïve temporal lobe epilepsy patients with depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Frontolimbic brain networks predict depressive symptoms in temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Validation of diagnostic tests for depressive disorder in drug-resistant mesial temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Validating screening tools for depression in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Identifying depression in epilepsy in a busy clinical setting is enhanced with systematic screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Patterns and frequency of the treatment of depression in persons with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: an in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Antidepressant-associated myoclonic status in a patient with symptomatic generalized epilepsy: does risk occur with therapeutic doses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Citalopram as a good candidate for treatment of depression in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Breakthrough seizures after starting vilazodone for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

The effects of chronic norepinephrine transporter inactivation on seizure susceptibility in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Treatment of depression in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Management and treatment of eating disorders with severe medical complications on a psychiatric ward: a study of 9 inpatients in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Revealing Medicinal Plants That Are Useful for the Comprehensive Management of Epilepsy and Associated Comorbidities through In Silico Mining of Their Phytochemical Diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

The anti-depression effect of Xylaria nigripes in patients with epilepsy: A multicenter randomized double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Cognitive behavior therapy for depression in people with epilepsy: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Treatment of depression in patients with temporal lobe epilepsy: A pilot study of cognitive behavioral therapy vs. selective serotonin reuptake inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Neuromodulation in the Treatment of Epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Ultrasound stimulation inhibits recurrent seizures and improves behavioral outcome in an experimental model of mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

The present indication and future of deep brain stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Slight improvement in mood and irritability after antiepileptic drug withdrawal: a controlled study in patients on monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

Tiagabine: The Safety Landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14737175.2016.1204233

10.1080/14737175.2016.1204233

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27327645%20AND%20SRC:MED&resulttype=core&format=json